CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-01-20 | HOLMES E CARMACK Director | Option exercise | +10,000 | $3.47 | $35K | 12,472 |
| 2010-01-20 | HOLMES E CARMACK Director | Option exercise | +10,000 | $3.12 | $31K | 22,472 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −3,900 | $9.00 | $35K | 18,572 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −1,000 | $9.01 | $9K | 17,572 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −800 | $9.04 | $7K | 16,772 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −3,400 | $9.05 | $31K | 13,372 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −2,200 | $9.06 | $20K | 11,172 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −2,300 | $9.07 | $21K | 8,872 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −100 | $9.08 | $908 | 8,772 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −1,300 | $9.08 | $12K | 7,472 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −500 | $9.09 | $5K | 6,972 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −400 | $9.10 | $4K | 6,572 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −800 | $9.12 | $7K | 5,772 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −1,300 | $9.13 | $12K | 4,472 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −1,500 | $9.14 | $14K | 2,972 |
| 2010-01-20 | HOLMES E CARMACK Director | Sale | −500 | $9.16 | $5K | 2,472 |
| 2010-01-20 | HOLMES E CARMACK Director | Option exercise · Non-Qualified Stock Option (Right to Buy) | −10,000 | 205,000 | ||
| 2010-01-20 | HOLMES E CARMACK Director | Option exercise · Non-Qualified Stock Option | −10,000 | 195,000 | ||
| 2009-12-21 | CALHOUN CHRISTOPHER J Chief Executive Officer | Option exercise | +62,500 | $3.00 | $188K | 162,500 |
| 2009-12-21 | CALHOUN CHRISTOPHER J Chief Executive Officer | Shares withheld for taxes | −31,250 | $5.71 | $178K | 131,250 |
Page 34 of 53 · 1,058 trades